U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|
Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Saysnews2023-09-14T18:20:16+00:00September 14th, 2023|The New York Times|
FDA Panel Recommends 2 RSV Vaccines for Older Adultsnews2023-03-01T21:29:15+00:00March 1st, 2023|The New York Times|
Un ensayo sobre cáncer da un resultado inesperado: remisión en todos los pacientesnews2022-06-07T09:00:17+00:00June 7th, 2022|The New York Times|
Small Study on Rectal Cancer Results in Remission in Every Patientnews2022-06-05T18:09:29+00:00June 5th, 2022|The New York Times|
The F.D.A. Suspends Use of Glaxo Antibody Drug in the U.S.news2022-04-05T22:36:24+00:00April 5th, 2022|The New York Times|
Unilever Pursues Glaxo and Pfizer Consumer Health Venturenews2022-01-17T17:10:52+00:00January 17th, 2022|The New York Times|
Covid Treatments Including Paxlovid Are Rationed as Cases Spikenews2022-01-06T22:11:24+00:00January 6th, 2022|The New York Times|
What Is 23andMe Doing With Your DNA?news2021-09-20T18:12:06+00:00September 20th, 2021|The New York Times|
